668 related articles for article (PubMed ID: 22195040)
1. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
2. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
3. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
4. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
Lu W; Li Y
J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
[TBL] [Abstract][Full Text] [Related]
6. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
Yu S; Wang Z; Su Z; Song J; Zhou L; Sun Q; Liu S; Li S; Li Y; Wang M; Zhang GQ; Zhang X; Liu ZJ; Lu D
BMC Complement Altern Med; 2018 Feb; 18(1):59. PubMed ID: 29444668
[TBL] [Abstract][Full Text] [Related]
7. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
8. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.
Zhang Y
Biochem Biophys Res Commun; 2017 Jul; 488(4):679-684. PubMed ID: 28427938
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
[TBL] [Abstract][Full Text] [Related]
10. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.
Cselenyi CS; Jernigan KK; Tahinci E; Thorne CA; Lee LA; Lee E
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8032-7. PubMed ID: 18509060
[TBL] [Abstract][Full Text] [Related]
11. Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions.
Zeng X; Huang H; Tamai K; Zhang X; Harada Y; Yokota C; Almeida K; Wang J; Doble B; Woodgett J; Wynshaw-Boris A; Hsieh JC; He X
Development; 2008 Jan; 135(2):367-75. PubMed ID: 18077588
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal region Mesd peptide mimics full-length Mesd and acts as an inhibitor of Wnt/β-catenin signaling in cancer cells.
Lin C; Lu W; Zhang W; Londoño-Joshi AI; Buchsbaum DJ; Bu G; Li Y
PLoS One; 2013; 8(2):e58102. PubMed ID: 23469146
[TBL] [Abstract][Full Text] [Related]
13. β-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein.
Kríz V; Pospíchalová V; Masek J; Kilander MB; Slavík J; Tanneberger K; Schulte G; Machala M; Kozubík A; Behrens J; Bryja V
J Biol Chem; 2014 Jan; 289(2):1128-41. PubMed ID: 24265322
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells.
Park JH; Kwon HY; Sohn EJ; Kim KA; Kim B; Jeong SJ; Song JH; Koo JS; Kim SH
Pharmacol Rep; 2013; 65(5):1366-74. PubMed ID: 24399733
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.
Arend RC; Londoño-Joshi AI; Samant RS; Li Y; Conner M; Hidalgo B; Alvarez RD; Landen CN; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2014 Jul; 134(1):112-20. PubMed ID: 24736023
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling.
Reinke L; Lam AP; Flozak AS; Varga J; Gottardi CJ
Biochem Biophys Res Commun; 2016 Feb; 470(3):606-612. PubMed ID: 26797284
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling.
Liu CC; Kanekiyo T; Roth B; Bu G
J Biol Chem; 2014 Oct; 289(40):27562-70. PubMed ID: 25143377
[TBL] [Abstract][Full Text] [Related]
18. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori-induced activation of beta-catenin involves low density lipoprotein receptor-related protein 6 and Dishevelled.
Gnad T; Feoktistova M; Leverkus M; Lendeckel U; Naumann M
Mol Cancer; 2010 Feb; 9():31. PubMed ID: 20137080
[TBL] [Abstract][Full Text] [Related]
20. Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer.
Arensman MD; Nguyen P; Kershaw KM; Lay AR; Ostertag-Hill CA; Sherman MH; Downes M; Liddle C; Evans RM; Dawson DW
Mol Cancer Res; 2015 Nov; 13(11):1509-19. PubMed ID: 26224368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
